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Tetramethylenedisulfotetramine Neurotoxicity:  
In vivo Validation of In Vitro Screen to Identify Potential Countermeasures  
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a Department of Environmental Health Sciences, School of Health Sciences & Practice and b Department of Cell Biology & Anatomy,  
New York Medical College, Valhalla, NY, and cDept of Medicine, Robert Wood Johnson Medical School, Piscataway, NJ  
ABSTRACT 
INTRODUCTION 
RESULTS RESULTS 
CONCLUSIONS 
Poster  ID 
1735 
Tetramethylenedisulfotetramine (TMDT), a synthetic neurotoxin, induces a seizure syndrome by blocking Cl- 
influx through the GABAA channel. This process leads to uncontrolled depolarization followed by excessive Ca2+ 
entry into neurons and potential excitotoxicity. No standardized, effective treatment for TMDT poisoning currently 
exists. Primary neuronal cultures were used to screen candidate countermeasures for alleviation of TMDT-
provoked hyperexcitability by monitoring changes in intracellular Ca2+ levels ([Ca2+]i). Agents antagonizing NMDA 
or β-adrenergic receptors reversed TMDT-induced increases in [Ca2+]i and displayed the best counteracting 
potential. We have commenced testing these in vitro leads in vivo. Adult male mice were injected with 0.25 
mg/kg TMDT subcutaneously followed by intraperitoneal monotherapy immediately after the first clonic seizure 
observed. They were continuously monitored over 1 hr, for the occurrence and severity of clonic and tonic-clonic 
seizures, and for 24-hr mortality. Our current results indicate that MK-801 is superior, completely eliminating 
tonic-clonic seizures and 24-hr mortality. At 40 mg/kg, memantine decreased mortality by 75%, however delayed 
tonic-clonic seizures were observed. Although both procyclidine and ketamine prevented tonic-clonic seizures at 
higher doses (60 and 70 mg/kg, respectively), they were not as effective in preventing TMDT-induced lethality. 
Propranolol was the least effective at reducing seizure severity and mortality rate. Altogether, our in vitro assay 
provides a useful screen to identify potential countermeasures against TMDT neurotoxicity. Positive leads are 
being tested and show activity in vivo, supporting utility of the screen.   
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 In vivo validation showed that all positive leads from in vitro screen significantly reduced 1-hr lethality and thus 
extended the time window for further intervention.  
 
 Diazepam, a GABAA receptor positive modulator, and MK-801, an NMDAR antagonist, reversed both TMDT-
evoked increase in [Ca2+]i in vitro as well as completely prevented occurence of tonic-clonic seizures and 24-hr 
lethality in vivo, thus representing superior treatments compared with other drugs tested. 
 
 Drugs of the same pharmacological class, such as NMDAR antagonists (MK801, memantine, ketamine, 
procyclidine), displayed differing efficacies in reversing the features of the TMDT toxidrome (tonic-clonic seizures 
vs lethality), likely due to different pharmacokinetics and pharmacodynamics including NMDAR binding properties. 
 
 No neuronal death has been observed 24 hrs following TMDT treatment in vitro or in vivo. 
 
 Our in vitro monitoring of Ca2+ fluxes represents a valid and useful medium-throughput screening tool to 
evaluate the neurotoxic effects and for a rapid identification of potential treatment candidates against TMDT, and 
most probably against other neurotoxins inducing lethal convulsions with concurrent rise of [Ca2+]i. 
 
 These results demonstrate reliability and validity of our in vitro method, serving as a very effective low-cost and 
time-saving alternative to animal experimentation during a search for an effective treatment. Nevertheless, in vivo 
testing is still needed to evaluate efficacy of positive hits against all of the symptoms of TMDT toxidrome, and to 
establish accurate dosing.  
 
 Exploitation of our in vitro approach may be particularly significant in cases of sudden accidental or intentional 
exposure to various neurotoxic agents inducing lethal seizures with concurent rise of [Ca2+]i and the need to 
promptly identify effective treatments. 
 
Acknowledgements: NIH CounterACT Program (1R21NS084900) for financial support and Drs. Janet Alder and Smita Varia of 
Robert Wood Johnson Medical School, Rutgers University, for assistance with tissue dissections. 
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Konnerth, Neuron 2012;73(5):862-85, Wang and Gruenstein, Brain Res 1997;767(2):239-49. 
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Effect of TMDT on Neuronal Cell Death 
No significant alteration in cell vitality was observed after 24-hr incubation of neurons with 50-500 µM TMDT in 
vitro as compared to untreated or vehicle-treated (H2O or DMSO) groups. Kainic acid at 1mM (positive control) 
induced a significant impairment of cell viability, as expected. Similarly, no cell death was observed in vivo 24 hrs 
after s.c. injection of sublethal dose of TMDT to rodents, in spite of occurrence of severe tonic-clonic seizures. In 
contrast, the treatment with 12.5 mg/kg of kainic acid i.p. (positive control) induced a visible neuronal cell death 
within the rodent cortex and hippocampus 24 hrs later. These data suggest different cellular responses after 
TMDT treatment as compared to kainic acid and no production of neuronal cell death by TMDT in vitro or in vivo.   
Effect of different drugs on TMDT-induced 
increase of [Ca2+]i  
Treatment of 14-16 DIV cortical cultures with 
10 µM TMDT increased peak amplitude but not 
frequency of [Ca2+]i oscillations. Subsequent 
injection of vehicle (Hankʼs solution) to the 
wells did not modify this effect, whereas certain 
pharmacological agents significantly altered 
TMDT-induced changes in these oscillations. 
NMDAR blockers (MK-801, ketamine, 
memantine, procyclidine) displayed a similar 
pattern of changes and led to a more persistent  
TMDT is a synthetic neurotoxic chemical formerly used worldwide as a rodenticide. Though its production, sale, 
and use are now banned, it is widely available, particularly in mainland China. TMDT is water soluble, odorless 
and tasteless, stable and persistent in the environment, making it an effective adulterant of food and water. 
TMDT mediates its neurotoxic effects by binding inside the GABAA channel and thus blocking the hyperpolarizing 
chloride ion influx. This leads to neuronal hyperexcitability and calcium dependent excitotoxicity due to an 
excessive Ca2+  influx into the cell via Ca2+calcium-permeable channels. Among these, the NMDA receptor 
(NMDAR) represents one of the main regulators of Ca2+ influx during (patho)physiological conditions.  
Since currently there is no standardized and effective treatment against TMDT and other GABAA receptor 
poisons, we tried to develop a medium throughput screening for faster identification of potential 
countermeasures against TMDT. For this purpose, we use dissociated primary cortical neurons, as an in vitro 
functional assay of neuronal excitability and neuronal cytotoxicity preserving sufficient biological context to allow 
identification of compounds with potential to prevent neurotoxicity. The mature (14-16 days in vitro (DIV)) 
neuronal culture exhibits spontaneous Ca2+ oscillations, which correspond to synchronized bursts of action 
potentials with attendant release of neurotransmitters. These oscillations can be altered by addition of different 
neurotoxins including TMDT, to the cells, to simulate in vivo changes resulting in [Ca2+]i flux in neuronal network 
with convulsive and often lethal outcomes. Here we aimed to validate several drug candidates from our in vitro 
screen to test them in vivo  based on  their ability to reduce TMDT-induced increase of [Ca2+]i. 
Material and Methods 
Cortical neurons were isolated from Sprague-Dawley rat embryos (E18) and cultured in Neurobasal medium + 
2% B27 + 0.5mM GlutaMax on poly-D-lysine coated 96-well plates. The cell culture between 14-16 DIV was 
used to screen the effect of TMDT on [Ca2+]i flux. Neurons were loaded with Calcium 6 fluorescent dye 
(Molecular Devices) and after 1-hr incubation monitored for Ca2+ oscillations using FlexStation 3 (Molecular 
Devices). Various drugs were tested to evaluate their counteracting efficacy against TMDT-induced changes in 
Ca2+ oscillations. OriginPro software was used to quantify the area under the curve per 100 seconds for each 
time interval (baseline, following TMDT injection and after each treatment). 
Simultaneously, in another set of experiments, 14-day old cultures were incubated with different concentrations 
of TMDT and kainic acid (positive control) to evaluate the neuronal cell death. Following 24-hr incubation with 
TMDT or kainic acid, the cell vitality was analyzed with the Alamar blue test. Relative fluorescence intensity was 
measured with FlexStation 3 every hour during a 4-hr time interval. GraphPad Prizm was used for statistical 
evaluations. Similarly, neuronal cell death was evaluated in vivo in brain sections from 24-hrs survivors of TMDT  
or kainic acid intoxication using FluroJade C staining. 
To validate our in vitro screening method and efficacy of drug candidates to ameliorate TMDT toxidrome, (seizure 
severity and lethality), adult male C57BL6 mice were injected with 0.25 mg/kg of TMDT s.c. Following 
occurrence of the first clonic seizure mice received a single treatment (i.p.) and observed for 1 hr for 
development of further seizures and for 1- and 24-hr lethality. Severity score was calculated for each mouse, 
drug and dose and graphed using GraphPad Prism. A significant difference between the each treatment vs the 
vehicle (sterile water) control was calculated using Studentʼs t-test.    
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All candidates except captopril (negative control) reduced 1-hr lethality comparing with the vehicle. However, 
only memantine, procyclidine, MK-801, ketamine and diazepam prevented tonic-clonic seizures. From among 
these drugs, MK-801 and diazepam completely rescued from lethality within 24 hrs. Severity scores confirmed 
statistically significant counteracting potential of memantine (20 and 40 mg/kg), MK-801 (1 mg/kg) and diazepam 
(5 mg/kg) against TMDT toxidrome in the following order diazepam>MK-801>memantine. Diazepam appeared to 
be superior in preventing all symptoms of intoxication scored. 
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alteration of TMDT effect. Diazepam, a GABAA receptor antagonist and propranolol, a β-adrenergic receptor 
blocker also showed significant improvements upon reduction of Ca2+ influx. Angiotensin-converting enzyme 
inhibitor, captopril, was not effective even at high concentrations used. Dose response analysis and evaluation of 
area under the curve showed that all the drugs tested, except captopril, reduced TMDT-induced raise in [Ca2+]i , 
thus suggesting their potential efficacy in preventing TMDT-induced  toxidrome in vivo. 
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CAPTOPRIL 
AREA UNDER THE CURVE ANALYSIS  In vivo validation of candidates from 
in vitro screening against TMDT-
induced seizures and lethality 
In adult male mice, TMDT induced 
symptoms in the following sequence: 
myoclonic whole body twitches, clonic 
seizures, and tonic-clonic seizure 
resulting in death within 1 hr. Vehicle or 
the treatment was given after the first 
clonic seizure and animals were 
observed up to 1 hr for seizures, and for 
lethality at 1- and 24-hr. Severity score 
which encompases both seizure severity 
and lethality was calculated for each 
animal, drug and dose: 1 for mice 
displaying one clonic seizure (complete 
prevention of neurotoxic effects), 2 – 
multiple clonic seizures, 3 – tonic-clonic 
seizure, 4 – lethality within 24 hrs, 5 – 
lethality within 1 hr (no efficacy). 
